Ginkgo Bioworks designs, engineers, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. Gingko Bioworks also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets. Tom Knight, Reshama Shetty, Jason Kelly, Barry Canton, and Austin Che founded Ginkgo Bioworks in 2009. Its headquarters in Boston in Massachusetts.
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Ginkgo Bioworks or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
EQUITYZEN and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.